Consultation on Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
Current status: Open
This consultation opened on June 10, 2025, and closes on September 8, 2025.
Health Canada is proposing revisions to its Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs.
Join in: How to participate
Share your ideas online
Please send your comments to brdd-cppic_brdd-cppci@hc-sc.gc.ca.
Who is the focus of this consultation
We are seeking comments from:
- biosimilar drug industry
- academics
- health system partners
- the public
Contact us
Centre for Policy, Pediatrics and International Collaboration
Biologic and Radiopharmaceutical Drugs Directorate
Health Products and Food Branch
Health Canada
Email: brdd-cppic_brdd-cppci@hc-sc.gc.ca
Page details
- Date modified: